nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—NCOA3—lung cancer	0.385	0.924	CbGaD
Amsacrine—NCOA3—Teniposide—lung cancer	0.29	0.676	CbGbCtD
Amsacrine—TOP2A—Teniposide—lung cancer	0.0426	0.0993	CbGbCtD
Amsacrine—ABCB1—lung cancer	0.0318	0.0763	CbGaD
Amsacrine—TOP2A—Etoposide—lung cancer	0.0188	0.0438	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—lung cancer	0.0128	0.0299	CbGbCtD
Amsacrine—ABCB1—Topotecan—lung cancer	0.00643	0.015	CbGbCtD
Amsacrine—ABCB1—Gefitinib—lung cancer	0.00588	0.0137	CbGbCtD
Amsacrine—CYP2D6—Gefitinib—lung cancer	0.00554	0.0129	CbGbCtD
Amsacrine—ABCB1—Vinorelbine—lung cancer	0.00453	0.0106	CbGbCtD
Amsacrine—CYP2D6—Vinorelbine—lung cancer	0.00427	0.00995	CbGbCtD
Amsacrine—ABCB1—Crizotinib—lung cancer	0.0036	0.0084	CbGbCtD
Amsacrine—ABCB1—Gemcitabine—lung cancer	0.00352	0.00821	CbGbCtD
Amsacrine—ABCB1—Erlotinib—lung cancer	0.00348	0.0081	CbGbCtD
Amsacrine—CYP2D6—Erlotinib—lung cancer	0.00328	0.00763	CbGbCtD
Amsacrine—ABCB1—Paclitaxel—lung cancer	0.00318	0.00742	CbGbCtD
Amsacrine—ABCB1—Irinotecan—lung cancer	0.00314	0.00732	CbGbCtD
Amsacrine—ABCB1—Vinblastine—lung cancer	0.00279	0.0065	CbGbCtD
Amsacrine—CYP2D6—Vinblastine—lung cancer	0.00263	0.00613	CbGbCtD
Amsacrine—ABCB1—Cisplatin—lung cancer	0.00256	0.00596	CbGbCtD
Amsacrine—ABCB1—Etoposide—lung cancer	0.00252	0.00586	CbGbCtD
Amsacrine—ABCB1—Docetaxel—lung cancer	0.0023	0.00536	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—lung cancer	0.00172	0.004	CbGbCtD
Amsacrine—ABCB1—Methotrexate—lung cancer	0.00166	0.00387	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—lung cancer	0.00162	0.00377	CbGbCtD
Amsacrine—NCOA3—respiratory system—lung cancer	0.00114	0.139	CbGeAlD
Amsacrine—NCOA3—bronchus—lung cancer	0.00094	0.114	CbGeAlD
Amsacrine—NCOA3—trachea—lung cancer	0.000844	0.102	CbGeAlD
Amsacrine—NCOA3—cardiac atrium—lung cancer	0.000793	0.0962	CbGeAlD
Amsacrine—NCOA3—Irinotecan—Topotecan—lung cancer	0.000791	0.273	CbGdCrCtD
Amsacrine—NCOA3—bone marrow—lung cancer	0.000669	0.0812	CbGeAlD
Amsacrine—NCOA3—Topotecan—Irinotecan—lung cancer	0.000657	0.227	CbGdCrCtD
Amsacrine—NCOA3—lung—lung cancer	0.000606	0.0736	CbGeAlD
Amsacrine—TOP2A—bronchus—lung cancer	0.000551	0.0669	CbGeAlD
Amsacrine—NCOA3—lymph node—lung cancer	0.000415	0.0503	CbGeAlD
Amsacrine—TOP2A—bone marrow—lung cancer	0.000393	0.0477	CbGeAlD
Amsacrine—TOP2A—lung—lung cancer	0.000356	0.0432	CbGeAlD
Amsacrine—KCNH2—cardiac atrium—lung cancer	0.000261	0.0316	CbGeAlD
Amsacrine—TOP2A—lymph node—lung cancer	0.000243	0.0295	CbGeAlD
Amsacrine—KCNH2—bone marrow—lung cancer	0.00022	0.0267	CbGeAlD
Amsacrine—ABCB1—respiratory system—lung cancer	0.000165	0.02	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—lung cancer	0.000143	0.0493	CbGdCrCtD
Amsacrine—ABCB1—epithelium—lung cancer	0.000138	0.0167	CbGeAlD
Amsacrine—KCNH2—lymph node—lung cancer	0.000136	0.0165	CbGeAlD
Amsacrine—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000127	0.0438	CbGdCrCtD
Amsacrine—ABCB1—trachea—lung cancer	0.000122	0.0148	CbGeAlD
Amsacrine—TOP2A—Irinotecan—Topotecan—lung cancer	0.000109	0.0375	CbGdCrCtD
Amsacrine—ABCB1—bone marrow—lung cancer	9.65e-05	0.0117	CbGeAlD
Amsacrine—TOP2A—Erlotinib—Gefitinib—lung cancer	9.48e-05	0.0327	CbGdCrCtD
Amsacrine—TOP2A—Topotecan—Irinotecan—lung cancer	9.03e-05	0.0311	CbGdCrCtD
Amsacrine—TOP2A—Etoposide—Teniposide—lung cancer	8.97e-05	0.0309	CbGdCrCtD
Amsacrine—ABCB1—lung—lung cancer	8.74e-05	0.0106	CbGeAlD
Amsacrine—TOP2A—Vindesine—Vinorelbine—lung cancer	8.07e-05	0.0278	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Teniposide—lung cancer	6.84e-05	0.0236	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vinblastine—lung cancer	6.45e-05	0.0223	CbGdCrCtD
Amsacrine—TOP2A—Methotrexate—Pemetrexed—lung cancer	6.44e-05	0.0222	CbGdCrCtD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—lung cancer	6.34e-05	0.0218	CbGdCrCtD
Amsacrine—TOP2A—Afatinib—Gefitinib—lung cancer	6.2e-05	0.0214	CbGdCrCtD
Amsacrine—TOP2A—Gefitinib—Erlotinib—lung cancer	6.08e-05	0.021	CbGdCrCtD
Amsacrine—ABCB1—lymph node—lung cancer	5.98e-05	0.00726	CbGeAlD
Amsacrine—Pain—Irinotecan—lung cancer	5.36e-05	0.000527	CcSEcCtD
Amsacrine—Mental disorder—Docetaxel—lung cancer	5.34e-05	0.000525	CcSEcCtD
Amsacrine—Hypotension—Cisplatin—lung cancer	5.32e-05	0.000523	CcSEcCtD
Amsacrine—Malnutrition—Docetaxel—lung cancer	5.31e-05	0.000522	CcSEcCtD
Amsacrine—Decreased appetite—Gemcitabine—lung cancer	5.31e-05	0.000522	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	5.3e-05	0.000521	CcSEcCtD
Amsacrine—Nausea—Topotecan—lung cancer	5.28e-05	0.000519	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Gemcitabine—lung cancer	5.27e-05	0.000518	CcSEcCtD
Amsacrine—Fatigue—Gemcitabine—lung cancer	5.26e-05	0.000518	CcSEcCtD
Amsacrine—Confusional state—Etoposide—lung cancer	5.26e-05	0.000517	CcSEcCtD
Amsacrine—Pain—Gemcitabine—lung cancer	5.22e-05	0.000513	CcSEcCtD
Amsacrine—Nausea—Erlotinib—lung cancer	5.22e-05	0.000513	CcSEcCtD
Amsacrine—Pancytopenia—Methotrexate—lung cancer	5.22e-05	0.000513	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—lung cancer	5.21e-05	0.000513	CcSEcCtD
Amsacrine—Diarrhoea—Vinorelbine—lung cancer	5.2e-05	0.000511	CcSEcCtD
Amsacrine—Infection—Etoposide—lung cancer	5.18e-05	0.000509	CcSEcCtD
Amsacrine—Feeling abnormal—Irinotecan—lung cancer	5.16e-05	0.000508	CcSEcCtD
Amsacrine—Confusional state—Paclitaxel—lung cancer	5.15e-05	0.000507	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—lung cancer	5.15e-05	0.000507	CcSEcCtD
Amsacrine—Gastrointestinal pain—Irinotecan—lung cancer	5.13e-05	0.000504	CcSEcCtD
Amsacrine—Paraesthesia—Cisplatin—lung cancer	5.11e-05	0.000503	CcSEcCtD
Amsacrine—Thrombocytopenia—Etoposide—lung cancer	5.1e-05	0.000502	CcSEcCtD
Amsacrine—Tachycardia—Etoposide—lung cancer	5.09e-05	0.0005	CcSEcCtD
Amsacrine—Infection—Paclitaxel—lung cancer	5.08e-05	0.000499	CcSEcCtD
Amsacrine—Dyspnoea—Cisplatin—lung cancer	5.07e-05	0.000499	CcSEcCtD
Amsacrine—Skin disorder—Etoposide—lung cancer	5.06e-05	0.000498	CcSEcCtD
Amsacrine—Feeling abnormal—Gemcitabine—lung cancer	5.03e-05	0.000495	CcSEcCtD
Amsacrine—Dizziness—Vinorelbine—lung cancer	5.03e-05	0.000494	CcSEcCtD
Amsacrine—Thrombocytopenia—Paclitaxel—lung cancer	5e-05	0.000492	CcSEcCtD
Amsacrine—Tachycardia—Paclitaxel—lung cancer	4.99e-05	0.000491	CcSEcCtD
Amsacrine—Anorexia—Etoposide—lung cancer	4.97e-05	0.000489	CcSEcCtD
Amsacrine—Skin disorder—Paclitaxel—lung cancer	4.97e-05	0.000488	CcSEcCtD
Amsacrine—Body temperature increased—Irinotecan—lung cancer	4.95e-05	0.000487	CcSEcCtD
Amsacrine—Abdominal pain—Irinotecan—lung cancer	4.95e-05	0.000487	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	4.95e-05	0.000487	CcSEcCtD
Amsacrine—Decreased appetite—Cisplatin—lung cancer	4.95e-05	0.000487	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Cisplatin—lung cancer	4.91e-05	0.000483	CcSEcCtD
Amsacrine—Anaemia—Docetaxel—lung cancer	4.91e-05	0.000483	CcSEcCtD
Amsacrine—Infestation NOS—Methotrexate—lung cancer	4.9e-05	0.000482	CcSEcCtD
Amsacrine—Infestation—Methotrexate—lung cancer	4.9e-05	0.000482	CcSEcCtD
Amsacrine—Anorexia—Paclitaxel—lung cancer	4.87e-05	0.000479	CcSEcCtD
Amsacrine—Hypotension—Etoposide—lung cancer	4.87e-05	0.000479	CcSEcCtD
Amsacrine—Pain—Cisplatin—lung cancer	4.87e-05	0.000479	CcSEcCtD
Amsacrine—Vomiting—Vinorelbine—lung cancer	4.83e-05	0.000475	CcSEcCtD
Amsacrine—Body temperature increased—Gemcitabine—lung cancer	4.83e-05	0.000475	CcSEcCtD
Amsacrine—Renal failure—Methotrexate—lung cancer	4.81e-05	0.000473	CcSEcCtD
Amsacrine—Rash—Vinorelbine—lung cancer	4.79e-05	0.000471	CcSEcCtD
Amsacrine—Dermatitis—Vinorelbine—lung cancer	4.79e-05	0.000471	CcSEcCtD
Amsacrine—Hypotension—Paclitaxel—lung cancer	4.78e-05	0.00047	CcSEcCtD
Amsacrine—Stomatitis—Methotrexate—lung cancer	4.77e-05	0.000469	CcSEcCtD
Amsacrine—Headache—Vinorelbine—lung cancer	4.76e-05	0.000468	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—lung cancer	4.76e-05	0.000468	CcSEcCtD
Amsacrine—Leukopenia—Docetaxel—lung cancer	4.75e-05	0.000467	CcSEcCtD
Amsacrine—Feeling abnormal—Cisplatin—lung cancer	4.69e-05	0.000461	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—lung cancer	4.68e-05	0.00046	CcSEcCtD
Amsacrine—Haematuria—Methotrexate—lung cancer	4.67e-05	0.000459	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—lung cancer	4.65e-05	0.000457	CcSEcCtD
Amsacrine—Hepatobiliary disease—Methotrexate—lung cancer	4.63e-05	0.000455	CcSEcCtD
Amsacrine—Hypersensitivity—Irinotecan—lung cancer	4.62e-05	0.000454	CcSEcCtD
Amsacrine—Convulsion—Docetaxel—lung cancer	4.6e-05	0.000452	CcSEcCtD
Amsacrine—Paraesthesia—Paclitaxel—lung cancer	4.59e-05	0.000451	CcSEcCtD
Amsacrine—Agranulocytosis—Methotrexate—lung cancer	4.57e-05	0.000449	CcSEcCtD
Amsacrine—Dyspnoea—Paclitaxel—lung cancer	4.56e-05	0.000448	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—lung cancer	4.53e-05	0.000446	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—lung cancer	4.52e-05	0.000444	CcSEcCtD
Amsacrine—Nausea—Vinorelbine—lung cancer	4.51e-05	0.000444	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—lung cancer	4.5e-05	0.000443	CcSEcCtD
Amsacrine—Body temperature increased—Cisplatin—lung cancer	4.5e-05	0.000442	CcSEcCtD
Amsacrine—Asthenia—Irinotecan—lung cancer	4.5e-05	0.000442	CcSEcCtD
Amsacrine—Fatigue—Etoposide—lung cancer	4.49e-05	0.000442	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	4.49e-05	0.000441	CcSEcCtD
Amsacrine—Pain—Etoposide—lung cancer	4.46e-05	0.000438	CcSEcCtD
Amsacrine—Decreased appetite—Paclitaxel—lung cancer	4.44e-05	0.000437	CcSEcCtD
Amsacrine—Haemoglobin—Methotrexate—lung cancer	4.42e-05	0.000434	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Paclitaxel—lung cancer	4.41e-05	0.000434	CcSEcCtD
Amsacrine—Fatigue—Paclitaxel—lung cancer	4.41e-05	0.000433	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—lung cancer	4.4e-05	0.000432	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—lung cancer	4.4e-05	0.000432	CcSEcCtD
Amsacrine—Asthenia—Gemcitabine—lung cancer	4.38e-05	0.000431	CcSEcCtD
Amsacrine—Pain—Paclitaxel—lung cancer	4.37e-05	0.00043	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—lung cancer	4.37e-05	0.00043	CcSEcCtD
Amsacrine—TOP2A—Vincristine—Vinorelbine—lung cancer	4.35e-05	0.015	CbGdCrCtD
Amsacrine—Urinary tract disorder—Methotrexate—lung cancer	4.34e-05	0.000427	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—lung cancer	4.33e-05	0.000426	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—lung cancer	4.31e-05	0.000424	CcSEcCtD
Amsacrine—Infection—Docetaxel—lung cancer	4.3e-05	0.000423	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—lung cancer	4.3e-05	0.000423	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—lung cancer	4.3e-05	0.000423	CcSEcCtD
Amsacrine—Diarrhoea—Irinotecan—lung cancer	4.29e-05	0.000422	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—lung cancer	4.26e-05	0.000419	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—lung cancer	4.24e-05	0.000417	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—lung cancer	4.24e-05	0.000417	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—lung cancer	4.24e-05	0.000417	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—lung cancer	4.23e-05	0.000416	CcSEcCtD
Amsacrine—Feeling abnormal—Paclitaxel—lung cancer	4.21e-05	0.000414	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—lung cancer	4.21e-05	0.000414	CcSEcCtD
Amsacrine—Hypersensitivity—Cisplatin—lung cancer	4.19e-05	0.000412	CcSEcCtD
Amsacrine—Gastrointestinal pain—Paclitaxel—lung cancer	4.18e-05	0.000411	CcSEcCtD
Amsacrine—Diarrhoea—Gemcitabine—lung cancer	4.18e-05	0.000411	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—lung cancer	4.17e-05	0.00041	CcSEcCtD
Amsacrine—Dizziness—Irinotecan—lung cancer	4.14e-05	0.000408	CcSEcCtD
Amsacrine—Urticaria—Etoposide—lung cancer	4.14e-05	0.000407	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—lung cancer	4.13e-05	0.000406	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—lung cancer	4.13e-05	0.000406	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—lung cancer	4.13e-05	0.000406	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—lung cancer	4.12e-05	0.000405	CcSEcCtD
Amsacrine—Abdominal pain—Etoposide—lung cancer	4.12e-05	0.000405	CcSEcCtD
Amsacrine—Asthenia—Cisplatin—lung cancer	4.08e-05	0.000402	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—lung cancer	4.08e-05	0.000401	CcSEcCtD
Amsacrine—TOP2A—Vinorelbine—Vinblastine—lung cancer	4.07e-05	0.014	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—lung cancer	4.07e-05	0.014	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—lung cancer	4.07e-05	0.014	CbGdCrCtD
Amsacrine—Urticaria—Paclitaxel—lung cancer	4.06e-05	0.000399	CcSEcCtD
Amsacrine—Hypotension—Docetaxel—lung cancer	4.05e-05	0.000398	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—lung cancer	4.04e-05	0.000398	CcSEcCtD
Amsacrine—Abdominal pain—Paclitaxel—lung cancer	4.04e-05	0.000397	CcSEcCtD
Amsacrine—Body temperature increased—Paclitaxel—lung cancer	4.04e-05	0.000397	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—lung cancer	4.01e-05	0.000394	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—lung cancer	3.99e-05	0.000392	CcSEcCtD
Amsacrine—Vomiting—Irinotecan—lung cancer	3.99e-05	0.000392	CcSEcCtD
Amsacrine—Mediastinal disorder—Methotrexate—lung cancer	3.96e-05	0.00039	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—lung cancer	3.96e-05	0.000389	CcSEcCtD
Amsacrine—Rash—Irinotecan—lung cancer	3.95e-05	0.000389	CcSEcCtD
Amsacrine—Dermatitis—Irinotecan—lung cancer	3.95e-05	0.000388	CcSEcCtD
Amsacrine—Headache—Irinotecan—lung cancer	3.93e-05	0.000386	CcSEcCtD
Amsacrine—Diarrhoea—Cisplatin—lung cancer	3.89e-05	0.000383	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—lung cancer	3.89e-05	0.000383	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—lung cancer	3.88e-05	0.000382	CcSEcCtD
Amsacrine—Vomiting—Gemcitabine—lung cancer	3.88e-05	0.000382	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—lung cancer	3.87e-05	0.000381	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—lung cancer	3.86e-05	0.00038	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—lung cancer	3.85e-05	0.000379	CcSEcCtD
Amsacrine—Rash—Gemcitabine—lung cancer	3.85e-05	0.000379	CcSEcCtD
Amsacrine—Dermatitis—Gemcitabine—lung cancer	3.85e-05	0.000378	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—lung cancer	3.84e-05	0.000378	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—lung cancer	3.83e-05	0.000376	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—lung cancer	3.83e-05	0.000376	CcSEcCtD
Amsacrine—Headache—Gemcitabine—lung cancer	3.82e-05	0.000376	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—lung cancer	3.81e-05	0.000374	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—lung cancer	3.81e-05	0.000374	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—lung cancer	3.79e-05	0.000372	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—lung cancer	3.77e-05	0.00037	CcSEcCtD
Amsacrine—Hypersensitivity—Paclitaxel—lung cancer	3.77e-05	0.00037	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—lung cancer	3.76e-05	0.00037	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—lung cancer	3.74e-05	0.000368	CcSEcCtD
Amsacrine—Asthenia—Etoposide—lung cancer	3.74e-05	0.000368	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—lung cancer	3.74e-05	0.000368	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—lung cancer	3.74e-05	0.000367	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—lung cancer	3.73e-05	0.000367	CcSEcCtD
Amsacrine—Nausea—Irinotecan—lung cancer	3.72e-05	0.000366	CcSEcCtD
Amsacrine—Pain—Docetaxel—lung cancer	3.71e-05	0.000364	CcSEcCtD
Amsacrine—Asthenia—Paclitaxel—lung cancer	3.67e-05	0.000361	CcSEcCtD
Amsacrine—Nausea—Gemcitabine—lung cancer	3.63e-05	0.000357	CcSEcCtD
Amsacrine—Vomiting—Cisplatin—lung cancer	3.62e-05	0.000356	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—lung cancer	3.61e-05	0.000355	CcSEcCtD
Amsacrine—Rash—Cisplatin—lung cancer	3.59e-05	0.000353	CcSEcCtD
Amsacrine—Dermatitis—Cisplatin—lung cancer	3.58e-05	0.000353	CcSEcCtD
Amsacrine—Feeling abnormal—Docetaxel—lung cancer	3.57e-05	0.000351	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—lung cancer	3.57e-05	0.000351	CcSEcCtD
Amsacrine—Gastrointestinal pain—Docetaxel—lung cancer	3.54e-05	0.000348	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—lung cancer	3.54e-05	0.000348	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—lung cancer	3.53e-05	0.000347	CcSEcCtD
Amsacrine—TOP2A—Vinblastine—Vinorelbine—lung cancer	3.5e-05	0.0121	CbGdCrCtD
Amsacrine—Diarrhoea—Paclitaxel—lung cancer	3.5e-05	0.000344	CcSEcCtD
Amsacrine—TOP2A—Vincristine—Vinblastine—lung cancer	3.48e-05	0.012	CbGdCrCtD
Amsacrine—Angiopathy—Doxorubicin—lung cancer	3.45e-05	0.00034	CcSEcCtD
Amsacrine—Dizziness—Etoposide—lung cancer	3.45e-05	0.000339	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—lung cancer	3.43e-05	0.000337	CcSEcCtD
Amsacrine—Body temperature increased—Docetaxel—lung cancer	3.43e-05	0.000337	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—lung cancer	3.43e-05	0.000337	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—lung cancer	3.42e-05	0.000337	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—lung cancer	3.4e-05	0.000334	CcSEcCtD
Amsacrine—Dizziness—Paclitaxel—lung cancer	3.38e-05	0.000332	CcSEcCtD
Amsacrine—Nausea—Cisplatin—lung cancer	3.38e-05	0.000332	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—lung cancer	3.36e-05	0.000331	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—lung cancer	3.33e-05	0.000328	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—lung cancer	3.32e-05	0.000326	CcSEcCtD
Amsacrine—Vomiting—Etoposide—lung cancer	3.31e-05	0.000326	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—lung cancer	3.31e-05	0.000326	CcSEcCtD
Amsacrine—Rash—Etoposide—lung cancer	3.29e-05	0.000323	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—lung cancer	3.28e-05	0.000323	CcSEcCtD
Amsacrine—Headache—Etoposide—lung cancer	3.27e-05	0.000321	CcSEcCtD
Amsacrine—Vomiting—Paclitaxel—lung cancer	3.25e-05	0.00032	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.24e-05	0.000318	CcSEcCtD
Amsacrine—Rash—Paclitaxel—lung cancer	3.22e-05	0.000317	CcSEcCtD
Amsacrine—Dermatitis—Paclitaxel—lung cancer	3.22e-05	0.000317	CcSEcCtD
Amsacrine—Headache—Paclitaxel—lung cancer	3.2e-05	0.000315	CcSEcCtD
Amsacrine—Hypersensitivity—Docetaxel—lung cancer	3.19e-05	0.000314	CcSEcCtD
Amsacrine—Confusional state—Methotrexate—lung cancer	3.15e-05	0.00031	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—lung cancer	3.12e-05	0.000307	CcSEcCtD
Amsacrine—Asthenia—Docetaxel—lung cancer	3.11e-05	0.000306	CcSEcCtD
Amsacrine—Infection—Methotrexate—lung cancer	3.1e-05	0.000305	CcSEcCtD
Amsacrine—Nausea—Etoposide—lung cancer	3.1e-05	0.000305	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—lung cancer	3.06e-05	0.000301	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—lung cancer	3.06e-05	0.000301	CcSEcCtD
Amsacrine—Nausea—Paclitaxel—lung cancer	3.04e-05	0.000299	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—lung cancer	3.03e-05	0.000298	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—lung cancer	2.98e-05	0.000293	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—lung cancer	2.97e-05	0.000292	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—lung cancer	2.96e-05	0.000292	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—lung cancer	2.92e-05	0.000287	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—lung cancer	2.87e-05	0.000282	CcSEcCtD
Amsacrine—Dizziness—Docetaxel—lung cancer	2.87e-05	0.000282	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.85e-05	0.000686	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—lung cancer	2.83e-05	0.00068	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EP300—lung cancer	2.81e-05	0.000675	CbGpPWpGaD
Amsacrine—Paraesthesia—Methotrexate—lung cancer	2.8e-05	0.000276	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.8e-05	0.000276	CcSEcCtD
Amsacrine—NCOA3—Metabolism—STK11—lung cancer	2.8e-05	0.000673	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—lung cancer	2.79e-05	0.000672	CbGpPWpGaD
Amsacrine—Dyspnoea—Methotrexate—lung cancer	2.78e-05	0.000274	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.77e-05	0.000665	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.76e-05	0.000663	CbGpPWpGaD
Amsacrine—Vomiting—Docetaxel—lung cancer	2.75e-05	0.000271	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	2.75e-05	0.000661	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—JUN—lung cancer	2.74e-05	0.000658	CbGpPWpGaD
Amsacrine—Rash—Docetaxel—lung cancer	2.73e-05	0.000269	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—lung cancer	2.73e-05	0.000268	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—SRC—lung cancer	2.73e-05	0.000656	CbGpPWpGaD
Amsacrine—Confusional state—Doxorubicin—lung cancer	2.73e-05	0.000268	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—lung cancer	2.71e-05	0.000267	CcSEcCtD
Amsacrine—Headache—Docetaxel—lung cancer	2.71e-05	0.000267	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—lung cancer	2.7e-05	0.000265	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—lung cancer	2.69e-05	0.000265	CcSEcCtD
Amsacrine—Infection—Doxorubicin—lung cancer	2.69e-05	0.000264	CcSEcCtD
Amsacrine—Pain—Methotrexate—lung cancer	2.67e-05	0.000263	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	2.67e-05	0.000641	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—lung cancer	2.66e-05	0.000639	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—lung cancer	2.65e-05	0.000637	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Doxorubicin—lung cancer	2.65e-05	0.00026	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—lung cancer	2.64e-05	0.00026	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—STAT3—lung cancer	2.63e-05	0.000633	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.63e-05	0.000632	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.63e-05	0.000632	CbGpPWpGaD
Amsacrine—Skin disorder—Doxorubicin—lung cancer	2.63e-05	0.000258	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—NRAS—lung cancer	2.63e-05	0.000631	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTP1—lung cancer	2.59e-05	0.000623	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP8—lung cancer	2.59e-05	0.000622	CbGpPWpGaD
Amsacrine—Anorexia—Doxorubicin—lung cancer	2.58e-05	0.000254	CcSEcCtD
Amsacrine—Nausea—Docetaxel—lung cancer	2.57e-05	0.000253	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—lung cancer	2.57e-05	0.000253	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.56e-05	0.000615	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Methotrexate—lung cancer	2.55e-05	0.000251	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	2.53e-05	0.000607	CbGpPWpGaD
Amsacrine—Hypotension—Doxorubicin—lung cancer	2.53e-05	0.000249	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—EP300—lung cancer	2.53e-05	0.000607	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CAT—lung cancer	2.52e-05	0.000606	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.52e-05	0.000606	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK3—lung cancer	2.51e-05	0.000604	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.51e-05	0.000602	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	2.5e-05	0.000601	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.49e-05	0.000599	CbGpPWpGaD
Amsacrine—Urticaria—Methotrexate—lung cancer	2.48e-05	0.000244	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	2.48e-05	0.000596	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	2.47e-05	0.000594	CbGpPWpGaD
Amsacrine—Abdominal pain—Methotrexate—lung cancer	2.47e-05	0.000243	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—lung cancer	2.47e-05	0.000243	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	2.46e-05	0.000592	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TYMS—lung cancer	2.46e-05	0.000591	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCB1—lung cancer	2.45e-05	0.000589	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—lung cancer	2.43e-05	0.000239	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—lung cancer	2.41e-05	0.000237	CcSEcCtD
Amsacrine—NCOA3—Metabolism—TYMS—lung cancer	2.41e-05	0.000579	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	2.39e-05	0.000575	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—lung cancer	2.39e-05	0.000575	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—lung cancer	2.38e-05	0.000572	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.36e-05	0.000567	CbGpPWpGaD
Amsacrine—Decreased appetite—Doxorubicin—lung cancer	2.35e-05	0.000231	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—MDM2—lung cancer	2.34e-05	0.000563	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.33e-05	0.00023	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—RAF1—lung cancer	2.33e-05	0.000561	CbGpPWpGaD
Amsacrine—Fatigue—Doxorubicin—lung cancer	2.33e-05	0.000229	CcSEcCtD
Amsacrine—Pain—Doxorubicin—lung cancer	2.31e-05	0.000227	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—lung cancer	2.3e-05	0.000226	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.29e-05	0.000551	CbGpPWpGaD
Amsacrine—TOP2A—Cytarabine—Gemcitabine—lung cancer	2.29e-05	0.00789	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—KRAS—lung cancer	2.26e-05	0.000543	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1A1—lung cancer	2.26e-05	0.000542	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.24e-05	0.000539	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	2.24e-05	0.000539	CbGpPWpGaD
Amsacrine—Asthenia—Methotrexate—lung cancer	2.24e-05	0.00022	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ERCC2—lung cancer	2.24e-05	0.000538	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—lung cancer	2.23e-05	0.000219	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—lung cancer	2.21e-05	0.000217	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—BIRC5—lung cancer	2.21e-05	0.000531	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	2.2e-05	0.000528	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	2.17e-05	0.000522	CbGpPWpGaD
Amsacrine—Urticaria—Doxorubicin—lung cancer	2.15e-05	0.000211	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—TERT—lung cancer	2.14e-05	0.000515	CbGpPWpGaD
Amsacrine—Abdominal pain—Doxorubicin—lung cancer	2.14e-05	0.00021	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—lung cancer	2.14e-05	0.00021	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—lung cancer	2.14e-05	0.00021	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.12e-05	0.000509	CbGpPWpGaD
Amsacrine—Dizziness—Methotrexate—lung cancer	2.07e-05	0.000203	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—lung cancer	2.06e-05	0.000495	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—lung cancer	2.05e-05	0.000492	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	2.03e-05	0.000489	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	2.03e-05	0.000487	CbGpPWpGaD
Amsacrine—Hypersensitivity—Doxorubicin—lung cancer	1.99e-05	0.000196	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—lung cancer	1.99e-05	0.000195	CcSEcCtD
Amsacrine—Rash—Methotrexate—lung cancer	1.97e-05	0.000194	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—lung cancer	1.97e-05	0.000193	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—lung cancer	1.96e-05	0.00677	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—lung cancer	1.96e-05	0.00677	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—lung cancer	1.96e-05	0.00677	CbGdCrCtD
Amsacrine—ABCB1—Allograft Rejection—CASP3—lung cancer	1.96e-05	0.000471	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—lung cancer	1.96e-05	0.00047	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—lung cancer	1.96e-05	0.00047	CbGpPWpGaD
Amsacrine—Headache—Methotrexate—lung cancer	1.96e-05	0.000192	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.95e-05	0.000468	CbGpPWpGaD
Amsacrine—Asthenia—Doxorubicin—lung cancer	1.94e-05	0.000191	CcSEcCtD
Amsacrine—NCOA3—Metabolism—APOA1—lung cancer	1.94e-05	0.000465	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—lung cancer	1.92e-05	0.000462	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	1.92e-05	0.000462	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—lung cancer	1.89e-05	0.000455	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.88e-05	0.000453	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	1.87e-05	0.000449	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	1.87e-05	0.000449	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	1.86e-05	0.000448	CbGpPWpGaD
Amsacrine—Nausea—Methotrexate—lung cancer	1.85e-05	0.000182	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.85e-05	0.000446	CbGpPWpGaD
Amsacrine—Diarrhoea—Doxorubicin—lung cancer	1.85e-05	0.000182	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—IL6—lung cancer	1.84e-05	0.000442	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—lung cancer	1.81e-05	0.000435	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	1.8e-05	0.000431	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—lung cancer	1.79e-05	0.000176	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	1.77e-05	0.000426	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—lung cancer	1.77e-05	0.000425	CbGpPWpGaD
Amsacrine—Vomiting—Doxorubicin—lung cancer	1.72e-05	0.000169	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	1.72e-05	0.000413	CbGpPWpGaD
Amsacrine—Rash—Doxorubicin—lung cancer	1.7e-05	0.000168	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—lung cancer	1.7e-05	0.000168	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—AKT1—lung cancer	1.7e-05	0.000408	CbGpPWpGaD
Amsacrine—Headache—Doxorubicin—lung cancer	1.69e-05	0.000167	CcSEcCtD
Amsacrine—NCOA3—Metabolism—POMC—lung cancer	1.68e-05	0.000404	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COL4A3BP—lung cancer	1.68e-05	0.000403	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AZIN2—lung cancer	1.68e-05	0.000403	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RB1—lung cancer	1.67e-05	0.0004	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—lung cancer	1.66e-05	0.0004	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—lung cancer	1.65e-05	0.000398	CbGpPWpGaD
Amsacrine—TOP2A—Azacitidine—Gemcitabine—lung cancer	1.64e-05	0.00566	CbGdCrCtD
Amsacrine—NCOA3—Metabolism—CREBBP—lung cancer	1.64e-05	0.000394	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.64e-05	0.000394	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—lung cancer	1.61e-05	0.000158	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.59e-05	0.000382	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	1.58e-05	0.00038	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COL4A3BP—lung cancer	1.58e-05	0.00038	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AZIN2—lung cancer	1.58e-05	0.00038	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—lung cancer	1.55e-05	0.000374	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—lung cancer	1.53e-05	0.000369	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	1.49e-05	0.000357	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—lung cancer	1.46e-05	0.000352	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ATP5H—lung cancer	1.42e-05	0.000342	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—lung cancer	1.42e-05	0.000341	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	1.38e-05	0.000333	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.37e-05	0.00033	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.36e-05	0.000326	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—lung cancer	1.35e-05	0.000326	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.35e-05	0.000324	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ATP5H—lung cancer	1.34e-05	0.000323	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—lung cancer	1.34e-05	0.000323	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.34e-05	0.000322	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—POMC—lung cancer	1.34e-05	0.000322	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—lung cancer	1.28e-05	0.000309	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.28e-05	0.000307	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	1.27e-05	0.000306	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.27e-05	0.000306	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLBD1—lung cancer	1.27e-05	0.000305	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—lung cancer	1.24e-05	0.000297	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.23e-05	0.000294	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.21e-05	0.000292	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.21e-05	0.000291	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.21e-05	0.000291	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—lung cancer	1.2e-05	0.000288	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLBD1—lung cancer	1.2e-05	0.000288	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—lung cancer	1.17e-05	0.000281	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD17B10—lung cancer	1.16e-05	0.000279	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	1.14e-05	0.000274	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—EP300—lung cancer	1.14e-05	0.000274	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.13e-05	0.000271	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—EP300—lung cancer	1.12e-05	0.000268	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	1.11e-05	0.000267	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD17B10—lung cancer	1.09e-05	0.000263	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.08e-05	0.00026	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CKB—lung cancer	1.08e-05	0.00026	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.08e-05	0.000259	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.07e-05	0.000256	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.04e-05	0.00025	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK3—lung cancer	1.02e-05	0.000245	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CKB—lung cancer	1.02e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM2—lung cancer	1.02e-05	0.000244	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CNDP2—lung cancer	1.02e-05	0.000244	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—lung cancer	9.92e-06	0.000239	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTMR3—lung cancer	9.88e-06	0.000237	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	9.67e-06	0.000232	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PGAM1—lung cancer	9.62e-06	0.000231	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CNDP2—lung cancer	9.57e-06	0.00023	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM2—lung cancer	9.57e-06	0.00023	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	9.41e-06	0.000226	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	9.39e-06	0.000226	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTMR3—lung cancer	9.31e-06	0.000224	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2A7—lung cancer	9.18e-06	0.000221	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	9.11e-06	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	9.08e-06	0.000218	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PGAM1—lung cancer	9.07e-06	0.000218	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDC4—lung cancer	8.98e-06	0.000216	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	8.66e-06	0.000208	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2A7—lung cancer	8.65e-06	0.000208	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDC4—lung cancer	8.47e-06	0.000204	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	8.43e-06	0.000203	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—lung cancer	8.26e-06	0.000198	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	8.21e-06	0.000197	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RRM1—lung cancer	8.18e-06	0.000197	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA3—lung cancer	8.18e-06	0.000197	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—lung cancer	8.15e-06	0.000196	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	7.8e-06	0.000188	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	7.76e-06	0.000187	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RRM1—lung cancer	7.71e-06	0.000185	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA3—lung cancer	7.71e-06	0.000185	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—B4GALT5—lung cancer	7.69e-06	0.000185	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	7.55e-06	0.000181	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA4—lung cancer	7.48e-06	0.00018	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	7.38e-06	0.000178	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA2—lung cancer	7.29e-06	0.000175	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—B4GALT5—lung cancer	7.25e-06	0.000174	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA4—lung cancer	7.05e-06	0.00017	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA1—lung cancer	7.04e-06	0.000169	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	6.98e-06	0.000168	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCC3—lung cancer	6.96e-06	0.000167	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA2—lung cancer	6.87e-06	0.000165	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—lung cancer	6.74e-06	0.000162	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKR1C1—lung cancer	6.74e-06	0.000162	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA1—lung cancer	6.63e-06	0.000159	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCC3—lung cancer	6.56e-06	0.000158	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGT1A1—lung cancer	6.54e-06	0.000157	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	6.41e-06	0.000154	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKR1C1—lung cancer	6.35e-06	0.000153	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNG11—lung cancer	6.31e-06	0.000152	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.2e-06	0.000149	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGT1A1—lung cancer	6.16e-06	0.000148	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDOA—lung cancer	6.01e-06	0.000144	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	5.97e-06	0.000143	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNG11—lung cancer	5.94e-06	0.000143	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA3—lung cancer	5.83e-06	0.00014	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADCY1—lung cancer	5.67e-06	0.000136	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG2—lung cancer	5.67e-06	0.000136	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDOA—lung cancer	5.66e-06	0.000136	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—lung cancer	5.56e-06	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPGDS—lung cancer	5.56e-06	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPP2R1B—lung cancer	5.53e-06	0.000133	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA3—lung cancer	5.49e-06	0.000132	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—lung cancer	5.39e-06	0.00013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADCY1—lung cancer	5.34e-06	0.000128	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG2—lung cancer	5.34e-06	0.000128	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2A6—lung cancer	5.33e-06	0.000128	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCLC—lung cancer	5.33e-06	0.000128	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—lung cancer	5.24e-06	0.000126	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPGDS—lung cancer	5.24e-06	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.24e-06	0.000126	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPP2R1B—lung cancer	5.21e-06	0.000125	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—lung cancer	5.08e-06	0.000122	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO1—lung cancer	5.06e-06	0.000122	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.05e-06	0.000121	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCLC—lung cancer	5.03e-06	0.000121	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2A6—lung cancer	5.03e-06	0.000121	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO1—lung cancer	4.76e-06	0.000115	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.73e-06	0.000114	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2E1—lung cancer	4.53e-06	0.000109	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NQO1—lung cancer	4.48e-06	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.28e-06	0.000103	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2E1—lung cancer	4.27e-06	0.000103	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NQO1—lung cancer	4.22e-06	0.000102	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—STK11—lung cancer	4.04e-06	9.71e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—STK11—lung cancer	3.81e-06	9.15e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—lung cancer	3.74e-06	8.99e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAT—lung cancer	3.64e-06	8.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—lung cancer	3.52e-06	8.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TYMS—lung cancer	3.48e-06	8.36e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—lung cancer	3.44e-06	8.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAT—lung cancer	3.43e-06	8.24e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—lung cancer	3.34e-06	8.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TYMS—lung cancer	3.28e-06	7.87e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—lung cancer	3.26e-06	7.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—lung cancer	3.24e-06	7.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ERCC2—lung cancer	3.23e-06	7.77e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—lung cancer	3.07e-06	7.38e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ERCC2—lung cancer	3.04e-06	7.32e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA1—lung cancer	2.79e-06	6.72e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA1—lung cancer	2.63e-06	6.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—lung cancer	2.55e-06	6.13e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—POMC—lung cancer	2.43e-06	5.84e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.4e-06	5.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CREBBP—lung cancer	2.37e-06	5.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—POMC—lung cancer	2.29e-06	5.5e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—lung cancer	2.24e-06	5.39e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CREBBP—lung cancer	2.23e-06	5.36e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—lung cancer	2.21e-06	5.32e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.11e-06	5.08e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—lung cancer	2.09e-06	5.02e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—lung cancer	1.96e-06	4.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—lung cancer	1.94e-06	4.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.84e-06	4.43e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—lung cancer	1.83e-06	4.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—lung cancer	1.69e-06	4.06e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—EP300—lung cancer	1.61e-06	3.87e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—lung cancer	1.59e-06	3.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—EP300—lung cancer	1.52e-06	3.65e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—lung cancer	1.19e-06	2.87e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.12e-06	2.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—lung cancer	9.74e-07	2.34e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—lung cancer	9.18e-07	2.21e-05	CbGpPWpGaD
